We are proud that the strategic partnership between Bayer AG and CRS Clinical Research Services Management GmbH, which has existed since 2013, has now been extended ahead of schedule, and we are pleased that we may continue to support Bayer AG as a reliable partner in its early clinical development. Bayer AG and CRS look back on a very long and successful collaboration, in the course of which CRS took over Bayer AG’s clinical pharmacology units in Berlin and Wuppertal and integrated them into CRS’s network of research centers in Germany. This partnership has enabled CRS to expand its expertise in cardiovascular and gynecological indications, and at the same time Bayer and CRS have succeeded over the years in dovetailing their processes more closely, qualitatively and efficiently.